Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Debra Ainge

- PMLiVE

Pfizer acquires option to license potential Parkinson’s treatment

Medgenesis cuts exclusive deal for its GDNF treatment

- PMLiVE

FDA approves AZ’s opioid-induced constipation drug Movantik

Trials showed positive reactions to the treatment

- PMLiVE

Eric Hansen takes the helm at PAN

He replaces Jon Linscott as MD at the UK creative agency

- PMLiVE

Vifor Pharma appoints Dario Eklund

He takes on the role of head of international business operations

- PMLiVE

Gilead’s simtuzumab fails pancreatic cancer trial

Showed little difference in progression-free survival compared to placebo results

- PMLiVE

Where is the future for pharma marketing?

Publicis’ Sam Welch on global shifts in the industry

- PMLiVE

Endo’s $2.2bn bid for Auxilium Pharma could thwart QLT deal

Auxilium in the $345m process of acquiring Canadian biotech company

- PMLiVE

AZ and Lilly set up BACE camp for Alzheimer’s

Lilly will pay AZ up to $500m in development and regulatory costs

- PMLiVE

Beard growing challenge to raise money for prostate cancer

OctoBeardFest follows huge success of Movember

- PMLiVE

Rosetta appoints creative director in healthcare

Scott Reese was most recently CEO of Wool Labs

- PMLiVE

Pharma is turning its attention to consumer healthcare

Pharma is no stranger to over-the-counter remedies but, as a number of recent deals show, consumer healthcare’s star is rising

- PMLiVE

Sovaldi deal for developing world ‘falls short’

Critics claim Gilead have allowed Indian companies to set their own price

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links